Lennart Minthon (Former)
11 – 20 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Economic Evaluation of Management of Dementia Patients - A Systematic Literature Review
(2018) In Working Papers
- Working paper/Preprint › Working paper
-
Mark
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
- Contribution to journal › Article
-
Mark
Economic Evaluation of Pharmacological Treatments in Dementia Disorders - A Systematic Literature Review
(2018) In Working Papers
- Working paper/Preprint › Working paper
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement
- Contribution to journal › Article
-
Mark
Use of flutemetamol F18-labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker levels: Total tau and phosphorylated tau as markers for rate of progression in Alzheimer’s disease.
(2018) Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting 2018
- Contribution to conference › Abstract
-
Mark
Economic Evaluation of Interventions for Screening of Dementia
(2018) In Working Papers
- Working paper/Preprint › Working paper
-
Mark
Dementia behaviour management programme at home : impact of a palliative care approach on care managers and professional caregivers of home care services
- Contribution to journal › Article
- 2017
-
Mark
Response to the Letter From Abid Iraqi, MD, CMD and Terry Hughes, RN, CS
- Contribution to journal › Letter
-
Mark
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
- Contribution to journal › Article
